Abivax S.A. IPO

Completed

Abivax S.A. completed its initial public offering on NASDAQ on October 20, 2023, pricing at $11.60 a share.

Ticker	ABVX
Exchange	NASDAQ
Status	Completed
Listing date	October 20, 2023
Offering price	$11.60
Shares offered	18,699,460
Total raised	$217M

The offering

Abivax S.A. sold 18,699,460 shares at $11.60 each on NASDAQ. Multiplied out, that is $216.9 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $217 million total recorded for the deal.

Company coverage

Abivax S.A. — quote, profile and latest news →

Other recent IPOs

First Breach, Inc. · August 12, 2026
Advasa Holdings, Inc. · August 11, 2026
Latigo Biotherapeutics, Inc. · August 4, 2026
BOA Acquisition Corp. II · August 3, 2026
Obsidian Therapeutics, Inc. · August 3, 2026
Attovia Therapeutics, Inc. · July 29, 2026
Game Your Game Inc. · July 27, 2026
Scribe Therapeutics, Inc. · July 21, 2026

Source: SEC EDGAR filings for Abivax S.A.. This page is general information, not investment advice.